DOI: 10.1055/s-00023610

Drug Research

References

Kohan DE, Fioretto P, Tang W. et al.
Long-term study of patients with type 2 diabetes and moderate renal impairment shows that dapagliflozin reduces weight and blood pressure but does not improve glycemic control.

Kidney Int. 2014;
85: 962-971

Download Bibliographical Data

Access:
Access:
Access: